Chau T. Dang

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

53h-index14.0kcitations313works16.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HER2/EGFR in Cancer Research(166), Cancer Treatment and Pharmacology(139), Breast Cancer Treatment Studies(107), Advanced Breast Cancer Therapies(50), Chemotherapy-induced cardiotoxicity and mitigation(46)

Publications313 total

Evaluating post-T-DXd treatment strategies in HER2-positive metastatic breast cancer
Breast Cancer Research and Treatment·2025Open Access
Supplementary Table S1-S2 from Cytochrome P450 Oxidoreductase (<i>POR</i>) Associated with Severe Paclitaxel-Induced Peripheral Neuropathy in Patients of European Ancestry from ECOG-ACRIN E5103
2025Open Access
NCCN Guidelines® Insights: Breast Cancer, Version 5.2025
Journal of the National Comprehensive Cancer Network·2025· 16 cited
IFN-γ downregulates miR-4319 to enhance NLRC5 and MHC-I expression in MHC-I-deficient breast cancer cells
Cancer Biology & Therapy·2025· 3 citedOpen Access
Abstract P5-03-09: Evaluating Post-T-DXd Treatment Strategies in HER2-positive Metastatic Breast Cancer
Clinical Cancer Research·2025
Cardiac Safety of Reduced Cardiotoxicity Surveillance During HER2-Targeted Therapy
JACC CardioOncology·2025· 7 citedOpen Access
Treatment patterns, genomic characteristics, and outcomes among patients with metastatic lobular breast cancer.
Journal of Clinical Oncology·2025
Survival Among Patients With <i>ERBB2</i>-Positive Metastatic Breast Cancer and Central Nervous System Disease
JAMA Network Open·2025· 5 citedOpen Access
Long-term cardiovascular consequences of cancer therapy-related cardiac dysfunction: insights from ventricular–arterial coupling and myocardial work
European Heart Journal - Imaging Methods and Practice·2025Open Access
Executive Summary of the American Radium Society Appropriate Use Criteria
American Journal of Clinical Oncology·2024
Evaluation of Target Damage Effect Based on LiDAR
2024
Invasive disease-free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab
npj Breast Cancer·2024· 1 citedOpen Access
A digital, decentralized trial of exercise therapy in patients with cancer
npj Digital Medicine·2024· 9 citedOpen Access
Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancer
npj Breast Cancer·2024· 8 citedOpen Access
Supplementary Table S1-S2 from Cytochrome P450 oxidoreductase&lt;i&gt;, POR, &lt;/i&gt;associated with severe paclitaxel-induced peripheral neuropathy in patients of European ancestry from ECOG-ACRIN E5103
2024Open Access
Breast cancer screening motivation among women: an application of self-determination theory
BMC Primary Care·2024· 1 citedOpen Access
Data from Cytochrome P450 oxidoreductase&lt;i&gt;, POR, &lt;/i&gt;associated with severe paclitaxel-induced peripheral neuropathy in patients of European ancestry from ECOG-ACRIN E5103
2024Open Access
Supplementary Table S1-S2 from Cytochrome P450 oxidoreductase&lt;i&gt;, POR, &lt;/i&gt;associated with severe paclitaxel-induced peripheral neuropathy in patients of European ancestry from ECOG-ACRIN E5103
2024Open Access
QSPC-12 CNS-ONLY DISEASE IS ASSOCIATED WITH LONGER SURVIVAL BUT HIGH CNS-RELATED MORTALITY IN PATIENTS WITH HER2+ BREAST CANCER
Neuro-Oncology Advances·2024Open Access
A Case of Cameron Lesions: An Overlooked Cause of Anemia in Patients With Gastrointestinal Bleeding and Hiatal Hernia
Cureus·2024· 3 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

Clifford A. Hudis(21), Hope S. Rugo(13), Harold J. Burstein(12), Larry Norton(11), Ian E. Krop(9), Eric P. Winer(9), William J. Gradishar(8), Shanu Modi(8), Maura N. Dickler(8), Sara M. Tolaney(8), Gabriella D’Andrea(8), Andrew D. Seidman(8), Lori J. Goldstein(7), Mark E. Robson(7), Antonio C. Wolff(7), Lisa A. Carey(7), Monica Fornier(7), Jame Abraham(6), Rebecca Aft(6), Kimberly H. Allison(6)